Introduction
Functionalized indoles are prevalent structural motifs in a large number of biologically active alkaloids and pharmaceuticals.
1 It is therefore not surprising that an enormous amount of effort has recently been devoted to the development of efficient methods for direct catalytic functionalization of indoles. 2 The majority of these studies have been focused on the Friedel-Crafts reaction and its enantioselective variants using a range of electrophilic reagents. 3 In this context, C-H functionalization of indoles with metal carbenes generated from -diazocarbonyl compounds under catalysis by metal complexes is a potentially powerful means for installing functionalized alkyl groups on the pyrrole portion of the indole ring system. 4, 5 Since publication of the seminal work of Davies and Lian on catalysis by Rh 2 (S-DOSP) 4 4 6 (Figure 1 ), 7 the development of an enantioselective version of this catalytic process has been a challenging objective. Very recently, Fox and co-workers made a major breakthrough in this field when they demonstrated that enantioselective C-H functionalization of indoles with ethyl -alkyl--diazoacetates under catalysis by Rh 2 (S-NTTL) 4 3 [8] [9] [10] provides -alkyl-substituted 3-indolylacetates in high yields and enantioselectivities (82-96% yields, 79-99% ee, Scheme 1). 11, 12 While the scope of the reaction was found to accommodate a wide array of substrates, an exceptionally high performance was achieved with diazoesters bearing longer-chained alkyl groups than -methyl substituent when N-aryl or N-alkyl indole --- Corresponding author. Tel.: +81-11-706-3236; fax: +81-11-706-4981; e-mail: hsmt@pharm.hokudai.ac.jp (S. Hashimoto). Using Rh 2 (S-PTTEA) 4 1f as a catalyst, we next examined the effects of the N-substitution of the indole ring ( Table 2) . As might be expected from precedents, 4,5g,5i,5l,11,22 the reaction of 6a with indoles 5b and 5c carrying strongly electron-withdrawing Boc or Ts groups failed to give the corresponding indole products 7b and 7c (entries 2 and 3); instead, azine derived from 6a was obtained as a major product. While the reaction of Nbenzylindole 5d proceeded smoothly to give 7d in 89% yield with 74% ee (entry 4), N-methoxymethyl (MOM)-protected indole 5e provided 7e in 83% yield and with a greatly improved enantioselectivity of 82% ee (entry 5). An examination of the temperature profile demonstrated that lowering the reaction temperature to −40 or −60 °C had only a marginal effect on enantioselectivity (78% and 75% ee), although a sharp drop in product yield was observed (70% and 64%, respectively, entries 6 and 7). The effects of the ester moiety were also evaluated. Reactions of 5e with tert-butyl and ethyl esters 6b and 6c resulted in lower enantioselectivities than that observed with 6a (45% and 41% ee, respectively, entries 8 and 9). These results demonstrate that the use of the 2,4-dimethyl-3-pentyl ester moiety 23 is crucial for a high degree of enantioselection. Under optimized reaction conditions, we then explored the scope of the reaction with respect to the indole component ( Table  3 ). The reaction with 2-methylindole derivative 5f resulted in only a trace amount of product 7h (entry 1), which was markedly different from Fox's result with ethyl -diazopropionate. 24 The reaction with 4-methylindole 5g afforded 7i in 72% yield and 69% ee (entry 2). The reaction was also tolerant of methoxy, bromo, and nitro groups at the 5-position of the N-MOMprotected indole nucleus (69-83% yields, 58-72% ee, entries 3-5). The highest enantioselectivity (86% ee) was obtained in the reaction with 7-methylindole 5k (entry 6).
A R T I C L E I N F O A B S T R A C T
To determine the preferred absolute configuration of 7e, we explored removal of the MOM protecting group (Scheme 2). Hydrolysis of 7e with 2 M HCl in THF followed by treatment with 15% NaOH 25 provided indole 9 in 51% yield. Treatment with BBr 3 , 26 aq. formic acid 27 or TMSI 28 gave a complex mixture of products. After considerable experimentation, the Fujioka protocol using a combination of TMSOTf and 2,2'-bipyridyl 29 proved to be the method of choice. Treatment of 7e with TMSOTf (2 equiv) and 2,2'-bipyridyl (3 equiv) in CH 2 Cl 2 at 0 °C led to the exclusive cleavage of the methyl ether linkage of Table 3 Enantioselective C-H functionalization of indoles 5f-k with 2,4-dimethyl-3-pentyl -diazopropionate 6a catalyzed by Rh2(S-PTTEA)4 1f Using the present catalytic protocol, we conducted an asymmetric synthesis of (+)--methyl-3-indolylacetic acid 11, 31 a phytohormone of the auxin class 32 and a constituent of a potent plant-growth inhibitor acremoauxin A 12 (Scheme 3). 33, 34 Alcohol ent-10 was prepared using Rh 2 (R-PTTEA) 4 oxidation of a primary alcohol tethered to an unmasked indole substituent to carboxylic acid in the total synthesis of (+)-asperazine. 35 Following this precedent, oxidation of alcohol ent-10 under standard Parikh-Doering conditions 36 38 This is the first catalytic asymmetric synthesis of the (+)--methyl-3-indolylacetic acid fragment of 12.
Conclusion
We have developed a catalytic enantioselective C-H functionalization protocol for N-methoxymethyl (MOM)-protected 2,3-unsubstituted indoles using 2,4-dimethyl-3-pentyl-diazopropionates. In this process, Rh 2 (S-PTTEA) 4 , which is characterized by an exceptionally bulky triethylmethyl group, has emerged as the catalyst of choice for providing -methyl-3-indolylacetates in high yields and with enantioselectivities of up to 86% ee. This represents the first example of a catalytic enantioselective C-H functionalization of 2,3-unsubstituted indoles with -diazopropionates. Using this methodology, we achieved the first catalytic asymmetric synthesis of the (+)--methyl-3-indolylacetic acid fragment of acremoauxin A. In our approach, the use of a MOM group as a protecting group on the indole nitrogen was not only crucial for high levels of enantioselection but also synthetically advantageous since the removal of the N-MOM group could be conducted efficiently under the Fujioka conditions. Further applications of this methodology to catalytic asymmetric synthesis of indole alkaloids as well as stereochemical studies are currently in progress.
Experimental

General
Optical rotations were measured on a JASCO P-1030 digital polarimeter at the sodium D line (589 nm). IR spectra were recorded on a JASCO FT/IR-5300 spectrometer and absorbance bands are reported in wavenumber (cm −1 ). 1 H NMR spectra were recorded on JEOL JNM-ECX 400P (400 MHz) spectrometer or JNM-ECA 500 (500 MHz) spectrometer. Chemical shifts are reported relative to internal standard (tetramethylsilane at  H 0.00 or CDCl 3 at  H 7.26). Data are presented as follows: chemical shift (, ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad), coupling constants, integration and assignment.
13
C NMR spectra were recorded on JEOL JNM-ECX 400P (100 MHz) spectrometer or JEOL JNM-ECA 500 (125 MHz) spectrometer. The following internal references were used (CDCl 3 at  77.0). EI mass spectra were recorded on a JEOL JMS-FABmate spectrometer, operating with ionization energy of 70 eV. ESI mass spectra were recorded on a JEOL JMS-T100LCP spectrometer. Column chromatography was carried out on Kanto silica gel 60 N (63-210 mesh). Analytical thin layer chromatography (TLC) was carried out on Merck Kieselgel 60 F 254 plates. Visualization was accomplished with UV light, anisaldehyde stain solution or phosphomolybdic acid stain solution followed by heating. Analytical high performance liquid chromatography (HPLC) was performed on a JASCO PU-1580 intelligent HPLC pump with JASCO UV-1575 intelligent UV/VIS detector. Detection was performed at 254 nm. Chiralcel OD-H, Chiralpak AD-H, Chiralpak IC columns (0.46 cm × 25 cm) and Chiralpak IC-3 column (0.46 cm × 15 cm) from Daicel were used. Retention times (t R ) and peak ratios were determined with JASCO-Borwin analysis system.
All non-aqueous reactions were carried out in flame-dried glassware under Ar atmosphere unless otherwise noted. Reagents and solvents were purified by standard means. Dehydrated CH 2 Cl 2 , THF and DMF were purchased from Kanto Chemical Co., Inc. Chiral dirhodium(II) carboxylates 1a-f 14a,17a,18a,21 and 2, 21 1-methoxymethylindole 5e, 39 1-methoxymethyl-5-nitroindole 5j 40 and -diazopropionates 6a, 23c 6b 41 and 6c 41 were prepared according to literature procedures.
Preparation of N-MOM-protected indoles
1-Methoxymethyl-2-methylindole 5f
A solution of 2-methylindole (1.00 g, 6.16 mmol) in DMF (5 mL) was added to a solution of NaH (60% in oil, 0.34 g, 8.38 mmol) in DMF (10 mL) at 0 °C. After stirring for 0.5 h at room temperature, MOMCl (0.70 mL, 9.22 mmol) was added to the reaction mixture. After stirring for 1 h, the reaction was quenched by addition of water (30 mL). The mixture was extracted with EtOAc (2 × 20 mL) and the combined organic layers were washed with water (30 mL) and brine (30 mL), and dried over anhydrous Na 2 SO 4 . Filtration and evaporation in vacuo furnished the crude product (1.65 g), which was purified by column chromatography (silica gel, 20:1 hexane/EtOAc) to provide 5f (1.20 g, 90%) as a colorless oil: TLC R f = 0. 38 
1-Methoxymethyl-4-methylindole 5g
According to the procedure for the preparation of 5f, 5g was prepared from 4-methylindole (0.500 g, 3.08 mmol). The crude product was purified by column chromatography (silica gel, 20:1 hexane/EtOAc) to provide the title compound (0.639 g, 96%) as a colorless oil: TLC R f = 0. 31 
5-Methoxy-1-methoxymethylindole 5h
According to the procedure for the preparation of 5f, 5h was prepared from 5-methoxyindole (0.500 g, 3.40 mmol). The crude product was purified by column chromatography (silica gel, 10:1 hexane/EtOAc) to provide the title compound (0.583 g, 90%) as a colorless oil: TLC R f = 0. 29 
5-Bromo-1-methoxymethylindole 5i
According to the procedure for the preparation of 5f, 5i was prepared from 5-bromoindole (0.500 g, 2.55 mmol). The crude product was purified by column chromatography (silica gel, 10:1 hexane/EtOAc) to provide the title compound (0.596 g, 97%) as a colorless oil: TLC R f = 0. 26 
1-Methoxymethyl-7-methylindole 5k
According to the procedure for the preparation of 5f, 5k was prepared from 7-methylindole (0.500 g, 3.08 mmol). The crude product was purified by column chromatography (silica gel, 20:1 hexane/EtOAc) to provide the title compound (0.658 g, 99%) as a colorless oil: TLC R f = 0. 25 
The preferred absolute configuration of 7a was not determined.
(R*)-2,4-Dimethyl-3-pentyl 2-[(1-benzyl)-1H-indol-3-yl]propionate 7d (Table 2, entry 4)
According to the typical procedure for C-H functionalization of indole, 7d was prepared from 1f (3.18 mg, 0.002 mmol, 1 mol %), 6a (39. 100:1 hexane/2-propanol; flow: 1.0 mL/min): t R = 16.0 min for minor enantiomer; t R = 17.7 min for major enantiomer. The preferred absolute configuration of 7d was not determined.
(R)-2,4-Dimethyl-3-pentyl 2-[(1-methoxymethyl)-1H-indol-3-yl]propionate 7e (Table 2, entry 5)
According to the typical procedure for C-H functionalization of indole, 7e was prepared from 1f (3.18 mg, 0.002 mmol, 1 mol %), 6a (79.3 mg, 0.400 mmol) and 1-methoxymethylindole 5e (77.4 mg, 0.480 mmol). The crude product was purified by column chromatography (silica gel, 5:1 hexane/Et 2 O) to provide 7e (111 mg, 83%) as a colorless oil: TLC R f = 0. 30 20480 . The enantiomeric excess of 7e was determined to be 82% by HPLC analysis with a Daicel Chiralpak IC column (eluent: 100:1 hexane/2-propanol; flow: 1.0 mL/min): t R (minor) = 9.8 min for (S)-7e; t R (major) = 11.0 min for (R)-7e.
(R*)-tert-Butyl 2-[(1-methoxymethyl)-1H-indol-3-yl]propionate 7f (Table 2, entry 8)
According to the typical procedure for C-H functionalization of indole, 7f was prepared from 1f (3.18 mg, 0.002 mmol, 1 mol %), tert-butyl -diazopropionate 6b (31.2 mg, 0.200 mmol) and 5e (38.7 mg, 0.24 mmol). The crude product was purified by column chromatography (silica gel, 10:1 hexane/EtOAc) to provide 7f (41.6 mg, 72%) as a colorless oil: TLC R f = 0. 15655 . The enantiomeric excess of 7f was determined to be 45% by HPLC with a Daicel Chiralpak OD-H column (eluent: 100:1 hexane/2-propanol; flow: 1.0 mL/min): t R = 10.6 min for major enantiomer; t R = 11.4 min for minor enantiomer. The preferred absolute configuration of 7f was not determined.
(R*)-Ethyl 2-[(1-methoxymethyl)-1H-indol-3-yl]propionate 7g (Table 2, entry 9)
According to the typical procedure for C-H functionalization of indole, 7g was prepared from 1f (3.18 mg, 0.002 mmol, 1 mol %), ethyl -diazopropionate 6c (25.6 mg, 0.200 mmol) and 5e (38.7 mg, 0.24 mmol). The crude product was purified by column chromatography (silica gel, 10:1→5:1 hexane/EtOAc) to provide 7g (36.0 mg, 69%) as a colorless oil: TLC R f = 0. NO 3 Na (M + Na) + 284.12571, found 284.12538. The enantiomeric excess of 7g was determined to be 32% by HPLC with a Daicel Chiralpak OD-H column (eluent: 9:1 hexane/2-propanol; flow: 1.0 mL/min): t R = 8.0 min for major enantiomer; t R = 10.7 min for minor enantiomer. The preferred absolute configuration of 7g was not determined.
(R*)-2,4-Dimethyl-3-pentyl 2-[(1-methoxymethyl-4-methyl)-1H-indol-3-yl]propionate 7i (Table 3, entry 2)
According to the typical procedure for C-H functionalization of indole, 7i was prepared from 1f (3.18 mg, 0.002 mmol, 1 mol %), 6a (39.7 mg, 0.200 mmol) and 1-methoxymethyl-4-methylindole 5g (42.1 mg, 0.24 mmol). The crude product was purified by column chromatography (silica gel 5-methoxy-1-methoxymethyl)-1H-indol-3-yl]propionate 7j (Table 3, entry  3) According to the typical procedure for C-H functionalization of indole, 7j was prepared from 1f (3.18 mg, 0.002 mmol, 1 mol %), 6a (39.7 mg, 0.200 mmol) and 5-methoxy-1-methoxymethylindole 5h (45.9 mg, 0.24 mmol). The crude product was purified by column chromatography (silica gel, 5:1 hexane/Et 2 O) to provide 7j (55.6 mg, 77%) as a colorless oil: TLC R f = 0. The preferred absolute configuration of 7j was not determined.
(R*)-2,4-Dimethyl-3-pentyl 2-[(5-bromo-1-methoxymethyl)-1H-indol-3-yl]propionate 7k (Table 3, entry 4)
According to the typical procedure for C-H functionalization of indole, 7k was prepared from 1f (3.18 mg, 0.002 mmol, 1 mol %), 6a (39.7 mg, 0.200 mmol) and 5-bromo-1-methoxymethylindole 5i (57.6 mg, 0.24 mmol). The crude product was purified by column chromatography (silica gel, 5:1 hexane/Et 2 O) to provide 7k (67.9 mg, 83%) as a colorless oil: TLC R f = 0. The enantiomeric excess of 7l was determined to be 72% by HPLC with a Daicel Chiralpak AD-H column (eluent: 9:1 hexane/2-propanol; flow: 1.0 mL/min): t R = 7.2 min for minor enantiomer; t R = 11.6 min for major enantiomer. The preferred absolute configuration of 7l was not determined. TMSOTf (0.061 mL, 0.33 mmol) was added to a solution of 7e (55.0 mg, 0.166 mmol) and 2,2'-bipyridyl (77.8 mg, 0.498 mmol) in CH 2 Cl 2 (1.0 mL) at 0 °C. After stirring for 0.5 h at 0 °C, the reaction was quenched by addition of water (3 mL). The mixture was extracted with EtOAc (2 × 5 mL), and the combined organic layers were washed with 1 M aq. HCl (2 × 3 mL), saturated aq. NaHCO 3 (3 mL) and brine (3 mL), and dried over anhydrous Na 2 SO 4 . Filtration and evaporation in vacuo furnished (R)-2,4-dimethyl-3-pentyl 2-[(1-hydroxymethyl)-1H-indol-3-yl]propionate 8 (60.5 mg), which was used without further purification. NaOH (66.4 mg, 1.66 mmol) was added to the solution of 8 (60.5 mg) in THF (3.6 mL) and water (0.4 mL). After stirring for 24 h at room temperature, the reaction was quenched with addition of saturated NH 4 Cl (10 mL). The mixture was extracted with EtOAc (2 × 10 mL), and the combined organic layers were washed with brine (10 mL) and dried over anhydrous Na 2 SO 4 . Filtration and evaporation in vacuo furnished the crude product (62.0 mg), which was purified by column chromatography (silica gel 
(R)-2-(1H-indol-3-yl)propane-1-ol 10 30
LiAlH 4 (22.7 mg, 0.598 mmol) was added to a solution of 9 (43.0 mg, 0.150 mmol) in THF (1.0 mL) at 0 °C. After stirring for 4 h at room temperature, the reaction was quenched with addition of water (0.023 mL). 15% aq. NaOH (0.023 mL) and water (0.069 mL) were added to the reaction mixture. After stirring for 0.5 h at room temperature, filtration and evaporation in vacuo furnished the crude product (34.8 mg), which was purified by column chromatography (silica gel According to the typical procedure for C-H functionalization of indole, ent-7e was prepared from Rh 2 (R-PTTEA) 4 
Synthesis of (S)-(+)
-
(S)-2,4-Dimethyl-3-pentyl 2-(1H-indol-3-yl)propionate ent-9
According to the procedure for the preparation of 9, ent-9 was prepared from ent-7e (185.4 mg, 0.559 mmol). The crude product was purified by column chromatography (silica gel, 6:1 hexane/EtOAc) to provide the title compound (156.0 mg, 97%) as a colorless oil: [] D 25 +40.6 (c 0.98, CHCl 3 ) for 83% ee.
(S)-2-(1H-indol-3-yl)propane-1-ol ent-10
30
According to the procedure for the preparation of 10, ent-10 was prepared from ent-9 (153.5 mg, 0.534 mmol). The crude product was purified by column chromatography (silica gel, 1:1 hexane/EtOAc) to provide the title compound (90. 
(S)-(+)--methyl-3-indolylacetic acid 11
31
SO 3 •pyridine complex (114 mg, 0.718 mmol) was added to a solution of ent-10 (30.0 mg, 0.171 mmol) and Et 3 N (0.11 mL, 0.789 mmol) in DMSO (1.0 mL) at room temperature. After stirring for 0.5 h at room temperature, the reaction mixture was poured into a mixture of saturated aq. NH 4 Cl (5 mL) and saturated aq. NaHCO 3 (5 mL). The mixture was extracted with EtOAc (2 × 5 mL) and the combined organic layers were washed with brine (5 mL) and dried over anhydrous Na 2 SO 4 . Filtration and evaporation in vacuo gave the crude aldehyde, which was used without further purification. NaH 2 PO 4 •H 2 O (534 mg, 3.42 mmol) and NaClO 2 (70.0 mg, 0.619 mmol) were added to the solution of the crude aldehyde in THF (1.0 mL), t BuOH (0.3 mL), 2-methyl-2-butene (0.3 mL) and water (1.0 mL). After stirring for 0.5 h, the reaction mixture was poured into saturated aq. NH 4 Cl (5 mL), and whole was extracted with EtOAc (2 × 5 mL). The combined organic layers were washed with brine (5 mL) and dried over anhydrous Na 2 SO 4 . Filtration and evaporation in vacuo furnished the crude product (109 mg), which was purified by column chromatography (silica gel, 1:1 hexane/EtOAc) to provide 11 (19.8 
